All In Biotech

Drug Trial Radar · NCT07732374

Long-Term Outcomes Following HBOT

Assessing Follow-Up Effects Post-Discontinuation of Hyperbaric Oxygen Therapy on Cognitive Function, Mental Health, and Quality of Life in Veterans

Last checked: Nov 20, 2026Latest source record: Jul 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

35

Planned (sponsor's estimate)

Start

Jun 18, 2026

Primary completion

Jun 18, 2027

Study completion Jun 18, 2027

Sponsor

Lead sponsor
Summit Hyperbarics and WellnessAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jul 28, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is designed to better understand the long-term effects of hyperbaric oxygen therapy (HBOT). Our goal is to determine whether improvements after treatment are maintained over time and whether additional benefits appear months after treatment has ended. We will evaluate changes in cognitive function, mental health, and daily functioning to help strengthen the scientific evidence supporting the use of HBOT and guide future treatment recommendations.

Conditions

  • Traumatic Brain Injury
  • Post-Concussive Symptoms
  • Post-Traumatic Stress Disorder

Interventions

  • Hyperbaric Oxygen Therapy (HBOT)Drug

    Hyperbaric Oxygen Therapy (HBOT): Participants will receive 100% medical oxygen (USP) administered under hyperbaric conditions at 2.0 atmospheres absolute (ATA) for 60 minutes with a scheduled air break over 40 treatment sessions.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. NeuroTraxTime frame: Baseline (post-HBOT completion) and 12 weeks after the final HBOT session
  2. PTSD Checklist for DSM-5 (PCL-5)Time frame: Baseline (post-HBOT completion) and 12 weeks after the final HBOT session
  3. Patient Health Questionnaire-9 (PHQ-9)Time frame: Baseline (post-HBOT completion) and 12 weeks after the final HBOT session
  4. Generalized Anxiety Disorder 7-item scale (GAD-7)Time frame: Baseline (post-HBOT completion) and 12 weeks after the final HBOT session
  5. World Health Organization Quality of Life (WHOQOL-BREF)Time frame: Baseline (post-HBOT completion) and 12 weeks after the final HBOT session

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Summit Hyperbarics and Wellness

    Boise, Idaho · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.